PAHC 18.61 (-1.43%)
US71742Q1067Drug ManufacturersDrug Manufacturers - Specialty & Generic

Phibro Animal Health (PAHC) Competitor Comparison

We are evaluating the key criteria listed to compare Phibro Animal Health (PAHC) against its competitors in the Drug Manufacturers - Specialty & Generic industry.

Linearity 5 years - PAHC ranking 12 / 54

These are the competitors of Phibro Animal Health in the industry Drug Manufacturers - Specialty & Generic ranked by linearity 5 years
1. Linc LNC
52.86
2. ProPhase Labs PRPH
32.25
3. Catalent CTLT
20.24
4. Organogenesis Holdings ORGO
19.01
5. Green Thumb Industries R9U2.F
16.23
6. Kamada KMDA
15.33
7. Zoetis ZTS
12.92
8. Avadel Pharmaceuticals AVDL
11.43
9. Amphastar Pharmaceuticals AMPH
8.77
10. Neoleukin Therapeutics NLTX
8.58
11. Alvotech ALVO
8.47
12. Phibro Animal Health PAHC
7.94
13. Alimera Sciences ALIM
7.82
14. Pacira BioSciences PCRX
7.38
15. Vifor Pharma G2AB.F
7.23
16. Curaleaf Holdings CURLF
6.97
17. PetIQ PETQ
6.43
18. Collegium Pharmaceutical COLL
6.03
19. Teva Pharmaceutical Industries TEVA
5.53
20. Cumberland Pharmaceuticals CPIX
5.33
21. Kolinpharma KIP.MI
4.88
22. Supernus Pharmaceuticals SUPN
4.08
23. Perrigo PRGO
3.92
24. Journey Medical DERM
3.72
25. Ayr Wellness 3KJB.F
3.71
26. Elanco Animal Health ELAN
3.6
27. Bausch Health Companies BHC
3.57
28. Taro Pharmaceutical Industries TARO
3.55
29. Ironwood Pharmaceuticals IRWD
3.1
30. Cronos Group CRON
2.91
31. Procaps Group PROC
2.59
32. Solid Biosciences SLDB
2.54
33. Theratechnologies THTX
2.52
34. Zynerba Pharmaceuticals ZYNE
2.47
35. Jupiter Wellness JUPW
2.39
36. Embecta EMBC
2.29
37. ANI Pharmaceuticals ANIP
2.23
38. Societal CDMO SCTL
2.21
39. Eagle Pharmaceuticals EGRX
2.19
40. Emergent BioSolutions EBS
2.16
41. SCYNEXIS SCYX
2.15
42. Relmada Therapeutics RLMD
2.06
43. Evolus EOLS
2.01
44. Clever Leaves Holdings CLVR
1.87
45. Alpha Teknova TKNO
1.83
46. OptiNose OPTN
1.83
47. Tilray Brands TLRY
1.8
48. Ascend Wellness Holdings AAWH
1.77
49. Biofrontera BFRI
1.74
50. Flora Growth FLGC
1.63
51. Universe Pharmaceuticals UPC
1.61
52. Regencell Bioscience Holdings RGC
1.58
53. Amneal Pharmaceuticals AMRX
1.35
54. Harrow Health HROW
0.63

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.